Sanara MedTech Shares Fall on Wider 4Q Loss

Dow Jones03-25

By Sarina Isaacs

Shares of Sanara MedTech dropped after the company widened its fourth-quarter loss despite a jump in revenue.

The stock was recently down 11% at $31.77. Shares are off about 12% over the past year.

The Fort Worth, Texas-based company said Tuesday it lost $1.5 million, or 18 cents a share, compared with a loss of $237,000, or three cents a share, in the same quarter a year earlier.

Revenue rose 49% to $26.3 million, primarily driven by sales of soft-tissue products in its surgical segment, said Chief Executive Ron Nixon.

Operating expenses rose by 51% to $24.4 million from $16.1 million in the prior year, including higher overhead and research-and-development costs. Interest expenses more than tripled year over year to $1.29 million from $287,000.

Write to Sarina Isaacs at sarina.isaacs@wsj.com

(END) Dow Jones Newswires

March 25, 2025 11:14 ET (15:14 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2522060290?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-25 23:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522060290","market":"other","top_or_hot":-1,"title":"Sanara MedTech Shares Fall on Wider 4Q Loss","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sarina Isaacs \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Sanara MedTech dropped after the company widened its fourth-quarter loss despite a jump in revenue. \n</p>\n<p>\n  The stock was recently down 11% at $31.77. Shares are off about 12% over the past year. \n</p>\n<p>\n  The Fort Worth, Texas-based company said Tuesday it lost $1.5 million, or 18 cents a share, compared with a loss of $237,000, or three cents a share, in the same quarter a year earlier. \n</p>\n<p>\n  Revenue rose 49% to $26.3 million, primarily driven by sales of soft-tissue products in its surgical segment, said Chief Executive Ron Nixon. \n</p>\n<p>\n  Operating expenses rose by 51% to $24.4 million from $16.1 million in the prior year, including higher overhead and research-and-development costs. Interest expenses more than tripled year over year to $1.29 million from $287,000. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sarina Isaacs at sarina.isaacs@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 25, 2025 11:14 ET (15:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanara MedTech Shares Fall on Wider 4Q Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanara MedTech Shares Fall on Wider 4Q Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-25 23:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sarina Isaacs \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Sanara MedTech dropped after the company widened its fourth-quarter loss despite a jump in revenue. \n</p>\n<p>\n  The stock was recently down 11% at $31.77. Shares are off about 12% over the past year. \n</p>\n<p>\n  The Fort Worth, Texas-based company said Tuesday it lost $1.5 million, or 18 cents a share, compared with a loss of $237,000, or three cents a share, in the same quarter a year earlier. \n</p>\n<p>\n  Revenue rose 49% to $26.3 million, primarily driven by sales of soft-tissue products in its surgical segment, said Chief Executive Ron Nixon. \n</p>\n<p>\n  Operating expenses rose by 51% to $24.4 million from $16.1 million in the prior year, including higher overhead and research-and-development costs. Interest expenses more than tripled year over year to $1.29 million from $287,000. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sarina Isaacs at sarina.isaacs@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 25, 2025 11:14 ET (15:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2522060290","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522060290","pubTimestamp":1742915640,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Sanara MedTech dropped after the company widened its fourth-quarter loss despite a jump in revenue.The stock was recently down 11% at $31.77. Shares are off about 12% over the past year.The Fort Worth, Texas-based company said Tuesday it lost $1.5 million, or 18 cents a share, compared with a loss of $237,000, or three cents a share, in the same quarter a year earlier.Revenue rose 49% to $26.3 million, primarily driven by sales of soft-tissue products in its surgical segment, said Chief Executive Ron Nixon.Operating expenses rose by 51% to $24.4 million from $16.1 million in the prior year, including higher overhead and research-and-development costs. Interest expenses more than tripled year over year to $1.29 million from $287,000.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","SMTI":"Sanara MedTech Inc."},"translate_title":"Sanara MedTech股价因第四季度亏损扩大而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SMTI":0.9},"content_text":"By Sarina Isaacs \n\n\n \n\n\n  Shares of Sanara MedTech dropped after the company widened its fourth-quarter loss despite a jump in revenue. \n\n\n  The stock was recently down 11% at $31.77. Shares are off about 12% over the past year. \n\n\n  The Fort Worth, Texas-based company said Tuesday it lost $1.5 million, or 18 cents a share, compared with a loss of $237,000, or three cents a share, in the same quarter a year earlier. \n\n\n  Revenue rose 49% to $26.3 million, primarily driven by sales of soft-tissue products in its surgical segment, said Chief Executive Ron Nixon. \n\n\n  Operating expenses rose by 51% to $24.4 million from $16.1 million in the prior year, including higher overhead and research-and-development costs. Interest expenses more than tripled year over year to $1.29 million from $287,000. \n\n\n \n\n\n  Write to Sarina Isaacs at sarina.isaacs@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2025 11:14 ET (15:14 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2522060290"}